Market Study on Molecular Diagnostics in Infectious Disease Testing: North America to Continue Leading Global Market Growth

Report Highlights

Molecular Diagnostics in Infectious Disease Testing Market - Scope of Report

Persistence Market Research recently published a new report on the molecular diagnostics in infectious disease testing market for the assessment period of 2022-2032. The report offers a close look at the evolving aspects of the market, and insights into the dynamics impacting market growth. It also focuses on key developments in the market, especially due to the COVID-19 pandemic situation that has affected people, globally. The report includes various macro- and micro-economic factors responsible for a significant impact on market growth.

The report on the molecular diagnostics in infectious disease testing market extensively focuses on the key trends shaping its growth. Additionally, the included opportunity analysis underlines untapped corners for aspiring players. The report also offers a holistic view of the incremental opportunity, which can further help readers make effective decisions for the growth of their businesses.

All stakeholders in the molecular diagnostics in infectious disease testing market can rely on the data offered in this report to make critical decisions. Moreover, the information offered in this report also can help new market entrants expand their bases in this space.

The report elaborates on both, historical and current trends shaping the molecular diagnostics in infectious disease testing market. The performance journey of the market has been drawn and analyzed to make the lucrative opportunities in the market evident to readers. The competitive landscape presented in the report gives a detailed outlook of the profiles of key companies manufacturing molecular diagnostics in infectious disease testing, along with their differential strategies and key focus areas.

Segmentation

The research study offers a detailed market taxonomy, wherein, key segments have been discussed in detail. The market is segmented on the basis of product, application, technique, end user, and region. Every segment is analyzed in detail, and data pertaining to the growth of each segment has been included in the study.

Product

• Instruments and Analyzers
• Assays and Reagents
• Services and Software

Application

• Hepatitis B
• Hepatitis C
• AIDS
• Tuberculosis
• Methicillin-Resistant Staphylococcus Aureus (MRSA)
• Hospital-Acquired Infections
• Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
• Human Papillomavirus (HPV) Infection
• Others

Technique

• Polymerase Chain Reaction (PCR)
• Isothermal Nucleic Acid Amplification Technology (INAAT)
• Microarrays
• Next-Generation Sequencing (NGS)
• Hybridization
• Others

End User

• Hospitals
• Private Labs
• Clinics
• Academic Institutes
• Laboratories
• Others

Region

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• Middle East & Africa

The research report includes a competitive landscape that provides a dashboard view of the key competitors operating in the market. Some of the market players included in this section are Abbott Laboratories, Becton, Dickinson and Company, bioMérieux, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Siemens AG, Veridex, LLC, Luminex Corp., GenMark Diagnostics, Inc., Qiagen N.V., Genomix Biotech, and bioTheranostics.

Key Questions Answered in Report

The research study on the manufacturing molecular diagnostics in infectious disease testing market offers inclusive insights about the growth of the market in the most comprehensive manner. Key insights offered in the report answer some of the most salient questions that assist stakeholders in gauging all the emerging possibilities.

• Will the polymerase chain reaction (PCR) segment continue driving the sales of molecular diagnostics in infectious disease testing market?
• How are technological developments aiding molecular diagnostics in infectious disease testing market?
• Which region is a key contributor to the global molecular diagnostics in infectious disease testing market?